Stay updated on SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.5 to v3.6.6. This represents a software version update and does not modify the study history data shown.
    Difference
    0.0%
    Check dated 2026-08-29T21:59:48.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the history, representing the latest platform update. The previous revision v3.6.4 is removed from the history listing.
    Difference
    0.0%
    Check dated 2026-08-08T17:41:45.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The Record History page now shows revision v3.6.4, replacing v3.6.3, indicating a software release for the site interface without altering study records.
    Difference
    0.0%
    Check dated 2026-07-25T09:27:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor platform update.
    Difference
    0.0%
    Check dated 2026-07-03T22:22:22.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The record history page now displays Revision: v3.6.2 instead of Revision: v3.6.0. This reflects a new version tag for the page's history content.
    Difference
    0.0%
    Check dated 2026-06-27T00:28:34.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    The record history shows the recruitment status changed from Active, not recruiting to Completed with a No longer looking for participants note; new status entries were added on 2026-06-04 and 2026-06-08, and the revision updated to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-12T16:40:06.000Z thumbnail image

Stay in the know with updates to SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.